These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31605605)

  • 21.
    Lin W; Chen X; Chen T; Liu J; Ye Y; Chen L; Qiu X; Chia-Hsien Cheng J; Zhang L; Wu J; Qiu S
    DNA Cell Biol; 2020 Jun; 39(6):1000-1011. PubMed ID: 32282241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long noncoding RNA lung cancer associated transcript 1 promotes proliferation and invasion of clear cell renal cell carcinoma cells by negatively regulating miR-495-3p.
    Wang LN; Zhu XQ; Song XS; Xu Y
    J Cell Biochem; 2018 Sep; 119(9):7599-7609. PubMed ID: 29932248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ciRS-7 expression on clear cell renal cell carcinoma progression.
    Zhao YH; Wang Z; Zhang N; Cui T; Zhang YH
    Chin Med J (Engl); 2020 Sep; 133(17):2084-2089. PubMed ID: 32496306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
    He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
    J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-337-3p suppresses the proliferation and metastasis of clear cell renal cell carcinoma cells via modulating Capn4.
    Zhuang Q; Shen J; Chen Z; Zhang M; Fan M; Xue D; Lu H; Xu R; He X; Hou J
    Cancer Biomark; 2018; 23(4):515-525. PubMed ID: 30452399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma.
    Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D
    Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of EGFR as a Novel Key Gene in Clear Cell Renal Cell Carcinoma (ccRCC) through Bioinformatics Analysis and Meta-Analysis.
    Wang S; Yu ZH; Chai KQ
    Biomed Res Int; 2019; 2019():6480865. PubMed ID: 30895194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MFN2 suppresses clear cell renal cell carcinoma progression by modulating mitochondria-dependent dephosphorylation of EGFR.
    Luo L; Wei D; Pan Y; Wang QX; Feng JX; Yu B; Kang T; Luo J; Yang J; Gao S
    Cancer Commun (Lond); 2023 Jul; 43(7):808-833. PubMed ID: 37378422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysregulation of the miR-25-IMPA2 axis promotes metastatic progression in clear cell renal cell carcinoma.
    Lin YF; Chou JL; Chang JS; Chiu IJ; Chiu HW; Lin YF
    EBioMedicine; 2019 Jul; 45():220-230. PubMed ID: 31202813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma.
    Liu Y; Tan X; Liu W; Chen X; Hou X; Shen D; Ding Y; Yin J; Wang L; Zhang H; Yu Y; Hou J; Thompson TC; Cao G
    Chin J Cancer; 2018 Jan; 37(1):2. PubMed ID: 29357946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of novel snoRNA-based biomarkers for clear cell renal cell carcinoma from urine-derived extracellular vesicles.
    Grützmann K; Salomo K; Krüger A; Lohse-Fischer A; Erdmann K; Seifert M; Baretton G; Aust D; William D; Schröck E; Thomas C; Füssel S
    Biol Direct; 2024 May; 19(1):38. PubMed ID: 38741178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
    Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
    Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NLRC5 mediates cell proliferation, migration, and invasion by regulating the Wnt/β-catenin signalling pathway in clear cell renal cell carcinoma.
    Wang Q; Ding H; He Y; Li X; Cheng Y; Xu Q; Yang Y; Liao G; Meng X; Huang C; Li J
    Cancer Lett; 2019 Mar; 444():9-19. PubMed ID: 30543814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTRF suppresses the progression of colorectal cancers.
    Wang F; Zheng Y; Orange M; Yang C; Yang B; Liu J; Tan T; Ma X; Chen T; Yin X; Tang X; Zhu H
    Oncotarget; 2017 Jul; 8(30):48650-48659. PubMed ID: 27203393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation.
    Liu T; Xiang W; Chen Z; Wang G; Cao R; Zhou F; Meng Z; Luo Y; Chen L
    Cell Death Dis; 2023 Nov; 14(11):774. PubMed ID: 38008826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
    Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
    Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-19a correlates with poor prognosis of clear cell renal cell carcinoma patients via promoting cell proliferation and suppressing PTEN/SMAD4 expression.
    Ma Q; Peng Z; Wang L; Li Y; Wang K; Zheng J; Liang Z; Liu T
    Int J Oncol; 2016 Dec; 49(6):2589-2599. PubMed ID: 27779660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
    Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
    Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma.
    Liu S; Ma X; Ai Q; Huang Q; Shi T; Zhu M; Wang B; Zhang X
    Urol Oncol; 2013 Aug; 31(6):938-48. PubMed ID: 21993533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinoma.
    Mizutani A; Koinuma D; Seimiya H; Miyazono K
    Oncogene; 2016 Jul; 35(27):3514-23. PubMed ID: 26522722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.